RKLB
Rocket Lab CorporationThesis. RKLB posted 63.5% revenue growth and 38% QoQ top-line acceleration in Q1 2026, establishing itself as the only credible commercial small-sat launch competitor post-SpaceX. The $76bn market cap embeds 112x P/S and 104x EV/Revenue against -24% EBITDA margin and -32% FCF margin, pricing in a mature aerospace prime despite 2,600 headcount and $200mm quarterly revenue run-rate. Maintain ACCUMULATE on secular space tailwinds and demonstrated launch cadence, but current entry demands SpaceX IPO euphoria fade and margin inflection proof by Q3 2026.
Scoreboard
RKLB closed at $131.16 on May 19, 2026, up 5.1% from prior close and just -5.2% off all-time highs printed intraday at $138.38—a 448% surge from $23.92 52-week low. The stock trades 63% above its 50-day MA ($80.47) and 101% above 200-day MA ($65.36), reflecting violent re-rating since Q4 2025. Consensus price target of $100.84 implies -23% downside from current levels, with the Street lagging a momentum-driven tape amid SpaceX IPO speculation and space sector rotation. Beta of 2.31 confirms extreme volatility.
QoQ Changes
Q1 2026 revenue hit $200.3mm vs $179.7mm in Q4 2025, a 11.5% QoQ acceleration and 63.5% YoY growth, marking best sequential print in eight quarters. EPS improved to -$0.07 from -$0.09 prior quarter, though net loss of -$45mm vs -$53mm in Q4 reflects operating leverage lag against gross profit expansion.
Gross margin expanded 820 bp QoQ to 38.2% in Q1 from 30.0% in Q4, driven by launch services mix shift and space systems scale. Operating margin improved 450 bp to -27.9% from -28.4%, while EBITDA margin swung violently to -15.3% from -3.3% in Q4, likely reflecting one-time charges or capitalization timing—the -24% TTM EBITDA margin remains deeply negative.
Operating cash flow and FCF data unavailable for Q1 in provided dataset, but -31.6% TTM FCF margin against $679mm LTM revenue implies -$215mm annual cash burn. Quick ratio of 3.87x and current ratio of 4.48x suggest near-term liquidity stress remains low despite elevated burn.
Net cash position of $1.24bn (total cash $1.38bn less $139mm debt) provides 5.8 quarters of runway at current burn, up from $1.1bn exiting Q4 2025. Debt-to-equity of 6.12x appears inflated by negative equity base ($3.17 book value per share against $131 market price). No material debt maturities flagged in data.
Forward P/E of -15,394x and EV/EBITDA of -431x are nonsensical given losses; the 112x P/S and 104x EV/Revenue represent 15x-20x premium to historical space SPAC cohort (SPCE, ASTR pre-collapse) and 8x-10x premium to mature aerospace (LMT ~2.0x P/S, NOC ~1.8x). Price-to-book of 41.4x reflects intangible-heavy SPAC structure and IP valuation.
Recent news flow highlights Motiv Space Systems acquisition (robotics pivot) and SpaceX IPO filing catalyzing sector momentum. Insider transactions show material equity grants vesting (General Counsel +77k shares, COO +81k shares in March 2026), typical for high-growth SPAC comp structures. No transformative M&A or restructuring announced in Q1 earnings.
Ownership & Insider Activity
Institutional ownership at 58.7% (Blackrock 6.6%, Vanguard 8.7%, Baillie Gifford 3.2%) provides float stability but limits upside volatility absorption. Insider ownership of 0.88% is negligible for a founder-led story, though CEO Peter Beck sold just $1.3mm in March 2026 against $131 stock—inconsequential. Short interest climbed 33.7% MoM to 33.3mm shares (5.79% float, 1.41 days-to-cover), signaling growing bearish conviction despite price strength. Director Slusky's $11.8mm sale of 100k shares on May 12 at ~$118 average is the only meaningful distribution signal in recent insider data.
Recent Insider Transactions
| Date | Insider | Position | Shares | Value |
|---|---|---|---|---|
| 2026-05-12 | SLUSKY ALEXANDER R | Director | 10,000 | $0.00 |
| 2026-05-12 | SLUSKY ALEXANDER R | Director | 100,000 | $11.8M |
| 2026-03-24 | KAMPANI ARJUN E | General Counsel | 77,189 | $0.00 |
| 2026-03-20 | SPICE ADAM C | Chief Financial Officer | 1,558 | $0.00 |
| 2026-03-06 | SAINTIL MERLINE A | Director | 18,126 | $1.4M |
| 2026-03-04 | KAMPANI ARJUN E | General Counsel | 52,472 | $3.7M |
Seven Essential Metrics
EBITDA margin of -24%, operating margin -22%, ROE -13.6%, ROA -6.6%—deep losses across all profitability vectors despite gross margin of 36.6%.
Revenue growth 63.5% YoY with 11.5% QoQ acceleration in Q1 2026; no earnings growth to measure given persistent losses.
FCF margin of -31.6% and negative FCF yield of -0.28% reflect heavy capex cycle for Neutron development and launch infrastructure.
Net cash position of $1.24bn and debt/equity 6.12x (distorted by negative equity); balance sheet clean with $139mm gross debt.
Beta 2.31, 448% 52-week price range, pre-profitability stage, and execution risk on Neutron ramp—bankruptcy risk low given cash but volatility extreme.
112x P/S, 104x EV/Revenue, -15,394x forward P/E—multiples embed flawless margin inflection and revenue scale over 3+ years.
SPAC structure and equity comp-heavy model (77k-81k share grants to execs in Q1) suggests ongoing dilution; no buyback program.
Zero dividend; all capital reinvested in Neutron development, manufacturing scale, and M&A—no yield for 5+ years minimum.
Competitive Snapshot
| Company | EBITDA Margin | 3Y Rev CAGR | FCF Margin | Leverage | Fwd P/E |
|---|---|---|---|---|---|
SPCE Virgin Galactic | ~-180% | ~NM | ~-250% | Net cash | NM |
ASTS AST SpaceMobile | ~-950% | ~NM | ~-400% | Net cash | NM |
PL Planet Labs | ~-15% | ~8% | ~-10% | Net cash | NM |
LMT Lockheed Martin | ~13% | ~3% | ~9% | 2.5x | ~18x |
RKLB sits between unprofitable space SPACs (SPCE, ASTS with triple-digit EBITDA losses) and mature aerospace primes (LMT at 13% EBITDA margin). Planet Labs at -15% EBITDA margin and ~15x P/S offers closest comp—RKLB's 112x P/S reflects 7x premium on superior revenue growth (63% vs 8%) but identical loss profile. The commercial space cohort has destroyed >$40bn in market cap since 2021 peaks; RKLB's survival hinges on Neutron launch cadence and Space Systems margin inflection that peers never achieved.
Business & Strategy
Dual segment model: Launch Services (Electron small-sat launcher, Neutron medium-lift in development) and Space Systems (spacecraft components, satellite buses, optical systems, constellation management). Q1 2026 saw Space Systems accelerate as Electron launch cadence stabilized at ~10 annual missions; revenue mix shifting toward higher-margin spacecraft hardware as Neutron capital peak passes.
Commercial satellite operators, government agencies (NASA, NRO, DoD), aerospace primes (Boeing, Lockheed for subcontract work), and emerging constellation operators (Synspective, Capella Space).
Launch services priced $7mm-$8mm per Electron mission; Space Systems sells reaction wheels, solar arrays, satellite buses ($5mm-$50mm contracts); recurring revenue from on-orbit management and data services nascent but growing.
Neutron R&D (carbon composite manufacturing, reusable engine development), Electron production (Rutherford engine manufacturing), Photon spacecraft production, and facility expansion in Long Beach and New Zealand—SG&A bloat typical of hypergrowth phase.
Narrow but real: RKLB is only non-SpaceX player with reliable small-sat launch cadence (50+ Electron missions flown), vertical integration from engines to spacecraft buses, and dual-use DoD certification. Moat deepens if Neutron captures medium-lift market gap between Falcon 9 and Chinese competitors, but current moat width insufficient to justify 112x P/S without flawless execution.
Monetary-Policy Sensitivity
- Duration effect on pre-profitability growth equity with 2028-2030 EPS inflection
- VC/growth capital reallocation into space sector as cost of capital compresses
- M&A currency appreciation for stock-funded tuck-in acquisitions like Motiv deal
RKLB exhibits extreme rate sensitivity given -$215mm annual cash burn, 2.31 beta, and equity-funded growth model—every 50bp cut extends runway, lowers WACC on Neutron NPV, and fuels speculative bid. However, current 112x P/S already embeds aggressive discount rate assumptions; incremental rate cuts likely drive +12-18% technical re-rating rather than fundamental repricing.
SWOT Analysis
- Only credible non-SpaceX small-sat launch provider with 50+ Electron missions and 95%+ reliability
- Vertical integration from engine production to spacecraft manufacturing lowers marginal launch cost
- Neutron medium-lift vehicle targets $40bn+ addressable market gap (mega-constellations, interplanetary missions)
- Strong DoD/NRO relationships provide recurring revenue backstop and national security moat
- Sustained -24% EBITDA margin and -32% FCF margin with no clear path to breakeven before 2027
- Neutron first flight delayed multiple times; single-vehicle concentration risk if development slips further
- Minuscule 0.88% insider ownership and director sales signal weak alignment at $131 entry
- Talent competition with SpaceX, Blue Origin for engineering talent driving SG&A inflation
- SpaceX Starlink Phase 2 and Amazon Kuiper demand 10,000+ satellite launches by 2030—Neutron positioned to capture 5-10% share
- Space Systems margin expansion as production scales (target 50%+ gross margin vs 38% today)
- M&A consolidation of distressed space SPACs (SPCE, ASTR assets) at pennies on dollar
- NASA Artemis lunar gateway and Mars missions require commercial launch partners—RKLB only non-SpaceX bidder with credibility
- SpaceX Falcon 9/Starship reusability cost curve obliterates small-sat launch economics—$1mm per launch target makes Electron uncompetitive
- Chinese state-owned launch providers (CASC, Galactic Energy) undercutting on price with 50%+ government subsidy
- Capital markets re-rate growth equity downward as Fed pivots hawkish—$1.24bn cash covers 5.8 quarters but equity raise at lower valuation dilutes existing holders
- Neutron development risk—single failure on debut launch torches $5bn+ market cap and ends medium-lift ambitions
Catalysts & Event Risks
- 2026-08-15Q2 2026 Earnings Release
Neutron first flight update, Space Systems margin trajectory, and cash burn guidance will determine if $75bn market cap defensible.
- Q4 2026Neutron Inaugural Launch
First Neutron flight (currently targeting late 2026) represents $20bn+ market cap event—success validates medium-lift thesis, failure risks -40% drawdown.
- 2026-06-30SpaceX IPO Pricing
SpaceX S-1 filing already lifting space sector; actual IPO pricing will set valuation benchmark and liquidity catalyst for RKLB as closest public comp.
- 2027-01-15FY 2026 Guidance & Profitability Path
Management must articulate credible EBITDA breakeven timeline (2027 or 2028) and Neutron revenue ramp to justify current multiple.
- Q3 2026DoD Space Development Agency Awards
SDA Tranche 3 contract awards for satellite buses and launch services—RKLB positioned for $500mm-$1bn multi-year program.
Neutron first flight in Q4 2026 is binary $20bn market cap event—options market pricing 35% implied volatility into year-end. SpaceX IPO creates rising tide for space sector but also sets brutal profitability benchmark that RKLB must eventually meet. Near-term catalysts tilted positive (Q2 earnings, DoD awards), but 12-18 month risk/reward hinges on margin inflection proof.
Technical Analysis
RKLB rallied 448% off $23.92 Oct 2025 low to $138.38 all-time high on May 19, 2026, closing at $131.16—a parabolic move on 32mm volume (135% of average). Current price sits 94% into 52-week range, indicating distribution risk near $140 ceiling. Key support at $100 (consensus price target and psychological level); break below $100 opens air pocket to $80 (50-day MA). Volume surge and 5.79% short interest climbing suggest late-stage momentum chase—technical setup favors taking chips off table above $125 rather than initiating fresh longs. RSI likely >75 (overbought), but momentum can persist into SpaceX IPO event.
Verdict
Macro context. Space sector benefits from dual secular tailwinds: (1) Mega-constellation buildouts (Starlink, Kuiper, OneWeb) driving 15-20% CAGR in launch demand through 2030, and (2) geopolitical competition (U.S.-China space race, DoD Space Force budget +12% YoY) prioritizing domestic launch capability. However, rising real yields and Fed terminal rate at 4.5% pressure long-duration growth equity—RKLB's 448% rally reflects sector rotation from AI/semis into under-owned space exposure, not fundamental re-rating. Macro risk tilts negative if Fed holds restrictive policy into 2027.
ACCUMULATE RKLB on secular space tailwinds and demonstrated launch execution, but current $131 entry embeds 3+ years of flawless Neutron development and margin inflection—downside to $100 consensus target outweighs near-term upside to $140 resistance. The stock trades 112x P/S against -24% EBITDA margin, pricing in a mature aerospace prime despite pre-profitability stage and binary Neutron risk. Ideal entry at $90-$100 on pullback post-SpaceX IPO euphoria fade or Neutron delay headlines; existing holders should trim above $125 and reload on $100 retest. The 12-18 month thesis hinges on Q3/Q4 2026 margin inflection proof—without EBITDA path to breakeven by 2027, this valuation is indefensible. Target $110 reflects 15% haircut to consensus, acknowledging execution risk and crowded positioning after 448% rally.
Data source: Yahoo Finance / yfinance · fetched 5/19/2026, 6:36:37 AM